Panel: Cell Therapy Infrastructure & Manufacturing Requirements for Commercialization
Cell Therapy Infrastructure & Manufacturing Requirements for Commercialization
Speakers:
Edward Tenthoff, Managing Director & Senior Research Analyst, Piper Jaffray (moderator)
Cindy Collins, CEO/General Manager, Purification & Analysis & Cell Therapy Businesses, GE Healthcare
Bruce Levine, Ph.D., Barbara & Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania
Robert Preti, Ph.D., Co-Founder & President, PCT, a Caladrius Company; SVP, Manufacturing & Technical Operations, CTO & Director, Caladrius Biosciences
David Sourdive, Ph.D., EVP, Corporate Development, Cellectis
Видео Panel: Cell Therapy Infrastructure & Manufacturing Requirements for Commercialization канала Alliance for Regenerative Medicine
Speakers:
Edward Tenthoff, Managing Director & Senior Research Analyst, Piper Jaffray (moderator)
Cindy Collins, CEO/General Manager, Purification & Analysis & Cell Therapy Businesses, GE Healthcare
Bruce Levine, Ph.D., Barbara & Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania
Robert Preti, Ph.D., Co-Founder & President, PCT, a Caladrius Company; SVP, Manufacturing & Technical Operations, CTO & Director, Caladrius Biosciences
David Sourdive, Ph.D., EVP, Corporate Development, Cellectis
Видео Panel: Cell Therapy Infrastructure & Manufacturing Requirements for Commercialization канала Alliance for Regenerative Medicine
Показать
Комментарии отсутствуют
Информация о видео
31 марта 2016 г. 1:40:45
00:52:34
Другие видео канала
![Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop](https://i.ytimg.com/vi/7RHMlzLNrQI/default.jpg)
![FDA Regulation of Cell and Gene Therapies: Facilitating Advanced Manufacturing](https://i.ytimg.com/vi/choG6ptJQMY/default.jpg)
![Plenary Session: The Evolution of Commercial Cell Therapy](https://i.ytimg.com/vi/fEuKArNnw-A/default.jpg)
![Stem cells - the future: an introduction to iPS cells](https://i.ytimg.com/vi/Q9-4SMGiKnE/default.jpg)
![BioCentriq](https://i.ytimg.com/vi/vtDNxIfRqgQ/default.jpg)
![Process Development Scientist](https://i.ytimg.com/vi/Y01BacDzZRg/default.jpg)
![AGTC](https://i.ytimg.com/vi/ArH6n82gzWw/default.jpg)
![Manufacturing CAR-T Cell Therapies: The Novartis Approach](https://i.ytimg.com/vi/Cmft6Sg8X3o/default.jpg)
![A-Gene: Process Development Using Quality by Design (QbD) Principles](https://i.ytimg.com/vi/1n1DXjFZTvU/default.jpg)
![AskBio](https://i.ytimg.com/vi/7vfkjtxdJlY/default.jpg)
![Adaptimmune](https://i.ytimg.com/vi/hICDMsA6Ysc/default.jpg)
![Autolus](https://i.ytimg.com/vi/nBnApdtZx-I/default.jpg)
![Aruvant](https://i.ytimg.com/vi/gnNI52LTM38/default.jpg)
![American Gene Technologies (AGT)](https://i.ytimg.com/vi/TOVeH8SmzyI/default.jpg)
![What are Induced Pluripotent Stem Cells? (iPS Cells)](https://i.ytimg.com/vi/i-QSurQWZo0/default.jpg)
![Avectas](https://i.ytimg.com/vi/UqYJi44aEwA/default.jpg)
![Stem cells basics animation](https://i.ytimg.com/vi/-8xHWhg6YQA/default.jpg)
![AGC Biologics](https://i.ytimg.com/vi/wpJ5c9fa6Q4/default.jpg)
![Aposcience](https://i.ytimg.com/vi/VaCoz8ea1g4/default.jpg)
![Avrobio](https://i.ytimg.com/vi/sDBx1oQYsh8/default.jpg)